Baktır, G. Et Al. 1984. Pharmacokinetic Consequences of Liver Disease for the Elimination of Triazolam. Ninth European Workshop on Drug Metabolism , (Nancy, France), 157.

Baktır, G., Karlaganis, G., Fisch, H. U., & Bircher, J., (1984). Pharmacokinetic Consequences of Liver Disease for the Elimination of Triazolam . Ninth European Workshop on Drug Metabolism (pp.157). Nancy, France

Baktır, GÜL Et Al. "Pharmacokinetic Consequences of Liver Disease for the Elimination of Triazolam," Ninth European Workshop on Drug Metabolism, Nancy, France, 1984

Baktır, GÜL Et Al. "Pharmacokinetic Consequences of Liver Disease for the Elimination of Triazolam." Ninth European Workshop on Drug Metabolism , Nancy, France, pp.157, 1984

Baktır, G. Et Al. (1984) . "Pharmacokinetic Consequences of Liver Disease for the Elimination of Triazolam." Ninth European Workshop on Drug Metabolism , Nancy, France, p.157.

@conferencepaper{conferencepaper, author={GÜL BAKTIR Et Al. }, title={Pharmacokinetic Consequences of Liver Disease for the Elimination of Triazolam}, congress name={Ninth European Workshop on Drug Metabolism}, city={Nancy}, country={France}, year={1984}, pages={157} }